Treatment-emergent mania/hypomania during antidepressant treatment with transcranial direct current stimulation (tDCS): A systematic review and meta-analysis

Brain Stimul. 2017 Mar-Apr;10(2):260-262. doi: 10.1016/j.brs.2016.11.005. Epub 2016 Nov 14.

Abstract

Background: Treatment-emergent mania/hypomania (TEM) is a possible adverse effect of pharmacological and non-pharmacological antidepressant treatments.

Objective: We performed a systematic review and meta-analysis to evaluate the risk of TEM in depressed patients during randomized, sham-controlled trials (RCTs).

Data sources: Medline database, from the first date available to August 12, 2016.

Results: From 283 references, 10 RCTs were identified. Only 3 of them described TEM. In active and sham groups, respectively, only 8 of 226 (3.5%) and 1 of 190 (0.5%) participants presented TEM. This difference was not statistically significant (OR = 1.79, 95% CI = 0.6 to 5.32). There were also five additional reports of TEM in participants not on RCTs. No risk factors for TEM were identified.

Limitations: Low number of studies and TEM reports.

Conclusion: Despite previous reports, active vs. sham tDCS was not associated with a significantly greater number of TEM episodes.

Keywords: Bipolar disorder; Major depressive disorder; Manic switch; Transcranial direct current stimulation; Treatment-emergent mania.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents / therapeutic use
  • Bipolar Disorder / chemically induced*
  • Bipolar Disorder / epidemiology
  • Bipolar Disorder / etiology*
  • Depressive Disorder / drug therapy
  • Depressive Disorder / epidemiology
  • Depressive Disorder / therapy
  • Humans
  • Randomized Controlled Trials as Topic / methods
  • Transcranial Direct Current Stimulation / adverse effects*

Substances

  • Antidepressive Agents